Sample size partial replicate design [Regulatives / Guidelines]

posted by d_labes  – Berlin, Germany, 2010-01-07 14:56 (5641 d 22:49 ago) – Posting: # 4573
Views: 6,623

Dear Helmut,

once again: Where does the sample size come from?
Can you please explain in a little bit more detail? df, design constant, exact or with non-central t? Or sample size for 2x2 multiplied by 0.75?

Don't call me obtrusive nitpicker :wink:. I'm interested in including this design (RRT, RTR, TRR, a 2-treatment-3-sequence-3-period design) into my "eierlegende wollmilchsau" but have not found any hint about sample size for ABE within that design up to now.
Do you have any reference for me?

Regards,

Detlew

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,675 registered users;
25 visitors (0 registered, 25 guests [including 7 identified bots]).
Forum time: 14:45 CEST (Europe/Vienna)

Philosophy, like medicine, has plenty of drugs, few good remedies,
and hardly any specific cures.    Sebastien-Roch Nicolas de Chamfort

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5